ARCHIVES

Guttmacher Named NICHD Director

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

November 16, 1979

ASCO honors physicians for clinical trials participation.

June 4, 2004

DRCCA Board Approves Concepts Of Four New Antismoking Projects

May 20, 1983

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

Hospitals Win Grants For Radiation Oncology Disparity Research.

January 3, 2003